目前关于心房 Amyloidosis 的观点:一个叙述性审查
Marco Tana1,2, Claudio Tana3, Maria Domenica Guglielmi1
1Internal Medicine and Cardiovascular Ultrasound Unit, Medical Department, St Annunziata Hospital, 66100 Chieti, Italy.
Reviews in cardiovascular medicine
|July 30, 2024
概括
心脏粉症 (CA) 涉及心脏中的蛋白质积累,影响生存. 早期诊断CA中心房参与,使用多模式成像改善了患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 心血管疾病 心血管疾病
- 氨基粉症是什么?
背景情况:
- 氨基粉症是一种由蛋白质积累引起的全身性疾病,会导致器官损伤.
- 心脏氨基粉症 (CA) 显著恶化患者的预后.
- 常见的CA类型包括轻链 (AL-CA) 和跨氨基粉症 (ATTR-CA,野生类型和遗传性).
研究的目的:
- 为了突出心脏粉样化症中心房参与的重要性.
- 强调早期诊断和有效治疗策略的必要性.
- 推一种多模式的方法来诊断CA中的心房参与.
主要方法:
- 对心脏粉症和心房干扰的现有文献的审查.
- 讨论成像技术的诊断进步.
- 重点是心声回声学 (标准和多普勒) 和心磁共振 (CMR).
主要成果:
- 在CA中,心房参与呈现出非特异性心房动,心房功能障碍或中风.
- 未经治疗的CA生存率很差 (7-9年),但治疗可以显著改善 (10-24年).
- 早期检测心房变化可以在解剖损伤之前,使及时干预成为可能.
结论:
- 前庭干涉在CA中很常见,但研究不足.
- 通过多模式成像 (心声谱,CMR) 早期诊断对于有效治疗和改善生存至关重要.
- 一个全面的诊断策略可以提高患者的预后,降低死亡率.
更多相关视频
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.4K
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
1.7K
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
